Video

Inside the complex, surprising world of MS comorbidities

Publish date: May 31, 2018

 

EXPERT ANALYSIS FROM THE CMSC ANNUAL MEETING


Other research coauthored by Dr. Tremlett has linked comorbidities in MS – specifically, hyperlipidemia, migraine, and three or more comorbidities – to higher risk of MS relapse (Neurology. 2017 Dec 12;89[24]:2455-61).

Dr. Tremlett reported having no relevant disclosures.

Pages

Recommended Reading

Interim Results Show Efficacy for a Novel MS Drug
MDedge Neurology
Wide variety of MS topics on tap at CMSC 2018
MDedge Neurology
Rehabilitation in MS is hot topic at CMSC 2018
MDedge Neurology
Neurology Board Review: Multiple Sclerosis
MDedge Neurology
CMSC looks to increase advocacy efforts to address looming concerns
MDedge Neurology
DMTs Are Associated With Reduced Stroke Risk in Patients With MS
MDedge Neurology
AAN Publishes Practice Guideline on DMTs for MS
MDedge Neurology
Do Cardiovascular Risk Factors Contribute to Brain Atrophy in MS?
MDedge Neurology
iPad app puts cognitive screening in the hands of MS patients
MDedge Neurology
Value-based care spawns new challenges for MS physicians
MDedge Neurology